TheraRadar
← Back
Data updated: Mar 29, 2026

ACROTECH BIOPHARMA

OncologyDermatology
Specialty

ACROTECH BIOPHARMA is a specialty pharmaceutical company focused on Oncology, Dermatology. Key products include BELEODAQ.

2008
Since
6
Drugs
-
Trials
2
Approved (2yr)

Key Drugs

EVOMELA
melphalan hydrochloride
Oncology
DNA 1 indications · 2016
BELEODAQ
belinostat
HDAC 1 indications · 2014
ADQUEY
difamilast
· 2026

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

ADQUEY 2026-02-12
Type 1 - New Molecular Entity
BELEODAQ 2024-11-19
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 77%
3 drugs Phase 3: 1 Phase 1: 5
Dermatology 23%
0 drugs Phase 3: 2

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Oncology, Dermatology
Baxter specialty
Oncology, Dermatology
Eli Lilly big-pharma
Oncology, Dermatology
Bayer big-pharma
Oncology, Dermatology
COSETTE other
Dermatology, Oncology